Resistance to Non-glycopeptide Agents in Serious Staphylococcus aureus Infections.

about

Synthetic Antibacterial Peptide Exhibits Synergy with Oxacillin against MRSA.

P2860

Q38637954-C65B3A59-9662-431E-B0E4-611BFD591E49

P2860

Resistance to Non-glycopeptide Agents in Serious Staphylococcus aureus Infections.

Item

http://www.wikidata.org/entity/Q39016281

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Resistance to Non-glycopeptide Agents in Serious Staphylococcus aureus Infections.

@en

Resistance to Non-glycopeptide Agents in Serious Staphylococcus aureus Infections.

@nl

type

Item

label

Resistance to Non-glycopeptide Agents in Serious Staphylococcus aureus Infections.

@en

Resistance to Non-glycopeptide Agents in Serious Staphylococcus aureus Infections.

@nl

prefLabel

Resistance to Non-glycopeptide Agents in Serious Staphylococcus aureus Infections.

@en

Resistance to Non-glycopeptide Agents in Serious Staphylococcus aureus Infections.

@nl

P1476

Resistance to Non-glycopeptide Agents in Serious Staphylococcus aureus Infections.

@en

P2093

Kyle C Molina

http://www.w3.org/2001/XMLSchema#string

Vanthida Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates

High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria.

Observation of "seesaw effect" with vancomycin, teicoplanin, daptomycin and ceftaroline in 150 unique MRSA strains.

Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the "seesaw effect")

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.

High vancomycin minimum inhibitory concentration and clinical outcomes in adults with methicillin-resistant Staphylococcus aureus infections: a meta-analysis.

Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus.

Phenotypic and genotypic characterization of daptomycin-resistant methicillin-resistant Staphylococcus aureus strains: relative roles of mprF and dlt operons

Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis.

Dissemination of the same cfr-carrying plasmid among methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococcal isolates in China

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11908-016-0553-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27873126

http://www.w3.org/2001/XMLSchema#string

Resistance to Non-glycopeptide Agents in Serious Staphylococcus aureus Infections.

about

P2860

P2860

Resistance to Non-glycopeptide Agents in Serious Staphylococcus aureus Infections.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698